GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.4403 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5513 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2 |
11.5356 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIK3CA, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR, XDH |
11.0064 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
8.2322 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, SRC, XDH |
7.95853 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
7.7974 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
7.55033 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, HSD17B2, HSP90AB1, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PPARG, PTGS2, SRC, TYR |
7.33533 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG, PTGS1, PTGS2 |
7.18204 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
7.08529 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
7.08529 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, PIK3CA, PPARA, PPARG, PTGS2, SRC, TYR |
7.08423 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
6.91058 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2 |
6.86628 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG |
6.80719 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.6221 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, NQO2, PPARG, PTGS1, PTGS2, TYR, XDH |
6.51059 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, SRC, XDH |
6.51059 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
6.47718 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
6.38068 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARG, PTGS2, SRC, XDH |
6.33506 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.24564 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PPARG, PTGS2, SRC, TYR |
6.14451 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B1, HSD17B2 |
5.87968 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.72062 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PPARG, PTGS2, SRC, XDH |
5.63105 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG |
5.61568 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC |
5.41587 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG, PTGS1, PTGS2 |
5.26891 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PPARG, PTGS2, SRC, TYR |
5.16865 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, HSP90AB1, PPARG, PTGS2, SRC, TYR |
5.13938 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CHRM1, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PPARG, PTGS1, PTGS2, SRC, XDH |
5.11501 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, HCAR2, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
5.06962 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, HCAR2, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
5.05442 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA9, CBR1, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSD17B2, HSP90AB1, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, SRC, TYR |
5.03901 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.95595 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD17B2, HSP90AB1, KDR, PIK3CA, PPARA, PPARG, SRC, TYR |
4.93474 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, MET, PIK3CA, PIK3CB, PPARG, SRC |
4.86783 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, HSP90AB1, NQO2, PTGS1 |
4.81948 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TYR |
4.81948 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.63746 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, HSP90AA1, KDR, PIK3CA, PIK3CB, SRC |
4.63746 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, HSD17B2, HSP90AB1, KDR, MMP9, PIK3CA, PIM1, PPARA, PPARG, PTGS2, SRC, TYR |
4.6328 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC |
4.62801 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PPARG, PTGS2, SRC |
4.50757 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, IGF1R, MMP2, PPARA, PPARG, PTGS2, SRC |
4.45914 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, FABP3, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, SRC, XDH |
4.45914 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.42523 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR |
4.36814 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARG, PTGS2, SRC |
4.36814 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, SRC |
4.313 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, FABP3, FABP4, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, SRC, XDH |
4.29508 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
4.25105 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APP, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, PIK3CA, PPARG, PTGS2, SRC |
4.09781 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
4.05052 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, PPARA, PPARG, PTGS2, SRC |
3.96724 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR |
3.89488 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.84631 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.82398 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.82398 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR |
3.82329 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA2, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR |
3.79367 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.76099 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, CYP1A1, CYP1B1, ESR1, FLT3, HSP90AB1, PPARG, PTGS2, SRC |
3.69867 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, SRC, XDH |
3.69867 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.69867 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.69867 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, PTGS2, SRC, TYR |
3.66233 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, SRC |
3.66125 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTGS2, SRC |
3.6475 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, SRC, XDH |
3.62614 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.60206 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.58025 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.54044 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, PTGS2 |
3.54044 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CHRM1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC |
3.5054 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PPARG, PTGS2, SRC |
3.47223 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PPARG, PTGS2, SRC |
3.47223 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.45774 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, PTGS2, SRC, TYR |
3.44448 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD17B1, HSD17B2 |
3.38187 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC |
3.38187 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, HSP90AB1, MET, MMP9, PPARA, SRC |
3.34788 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CB, PPARA, PPARG, PTGS2, SRC |
3.32834 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.29023 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.27438 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.27026 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, HSP90AA1, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
3.2546 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
3.18016 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.16202 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, PTGS2, SRC, TYR |
3.16185 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC |
3.15493 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, FLT3, KDR, MET, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.15493 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PPARG, PTGS2, SRC |
3.12858 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX5, APP, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, ESR1, FABP4, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
3.08155 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.07951 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, ESR1 |
3.03296 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.96477 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.95961 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, HSP90AB1, MET, MMP9, PPARA, PPARG, SRC |
2.95961 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, PPARA, PPARG, PTGS2, SRC |
2.90775 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, FABP4, FLT3, HSP90AA1, HSP90AB1, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.8949 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, SRC |
2.8949 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, FABP3, HSP90AB1, KDR, PPARG, PTGS2, SRC |
2.8949 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.89448 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC |
2.85916 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARG, PTGS2, SRC |
2.85802 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, HCAR2, KDR, PIK3CB, PTGS2, SRC |
2.85802 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
2.82881 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, PIM1, PPARA, PPARG, SRC |
2.75346 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.73761 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, CYP19A1, ESR1, HSD17B2, HSP90AB1, PPARG, SRC |
2.71603 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.70709 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.68849 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, ESR1, FABP4, HSP90AA1, HSP90AB1, IGF1R, MET, MMP2, PPARA, PPARG, PTGS2, SRC, XDH |
2.67864 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, ESR1, FABP3, FABP4, MET, PIK3CA, PIK3CB, PPARG |
2.66359 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.66359 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, SRC |
2.66359 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, HCAR2, PIK3CA, PIK3CB, PPARG, SRC |
2.65642 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, HSP90AB1, KDR, PTGS2, SRC |
2.6207 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM5, FABP3, PPARA, PPARG |
2.61241 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CHRM1, CYP19A1, HCAR2, HSP90AB1, PPARG, PTGS2, SRC |
2.59465 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARG, PTGS2, SRC |
2.54322 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.51876 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, AURKB, AXL, CBR1, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
2.50765 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50635 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.46302 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, CHRM5, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.46302 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, SRC, XDH |
2.44814 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.43271 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.43271 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PPARG, PTGS2, SRC, XDH |
2.43244 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, CHRM5, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.43196 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.4135 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, PIK3CA, PIK3CB, PPARG, SRC |
2.41335 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, ESR1, HCAR2, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIM1, PPARG, PTGS2, SRC, XDH |
2.39883 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.39015 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC, XDH |
2.39015 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, ESR1, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SRC, XDH |
2.38569 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PPARG, PTGS2 |
2.37987 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.37738 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PPARG, PTGS2, SRC |
2.35856 |
[BP] GO:0038096 |
Fc-gamma receptor signaling pathway involved in phagocytosis
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, SRC |
2.35856 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, PPARA, PPARG, SRC |
2.35856 |
[BP] GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, SRC |
2.35856 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.3561 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35279 |
[BP] GO:0002431 |
Fc receptor mediated stimulatory signaling pathway
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, SRC |
2.33327 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, HSP90AA1, HSP90AB1, MMP9, XDH |
2.33128 |
[BP] GO:0038094 |
Fc-gamma receptor signaling pathway
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, SRC |
2.3084 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.30836 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30836 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CHRM1, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS2 |
2.30518 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.29373 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.29373 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.29373 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29373 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SRC, XDH |
2.29363 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, HCAR2, PIK3CB, PTGS2 |
2.28269 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, ESR2, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, SRC, XDH |
2.26347 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.23534 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SRC, XDH |
2.21473 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CHRM1, CYP19A1, HCAR2, HSP90AB1, MMP9, PIK3CB, PPARA, PPARG, PTGS2, SRC |
2.20802 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, MMP9, PPARG, PTGS2, SRC, XDH |
2.19464 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CSNK2A1, ESR1, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, SRC, XDH |
2.1895 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, FABP3, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.16206 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, FABP3, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.16206 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, FLT3, PPARG |
2.16206 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2 |
2.16206 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.16188 |
[BP] GO:0046320 |
None
|
FABP3, PPARA, PPARG |
2.1593 |
[BP] GO:0008217 |
None
|
ADORA1, PPARA, PPARG, PTGS1, PTGS2 |
2.15167 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC |
2.11966 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.11966 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.11966 |
[BP] GO:0010891 |
None
|
PPARA, PPARG |
2.11966 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.10807 |
[BP] GO:0070542 |
None
|
FABP3, PPARG, PTGS2, SRC |
2.09301 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, HSP90AB1, MMP2, PPARA, PPARG, PTGS2, SRC |
2.0895 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.0895 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, CHRM3, PTGS2, SRC |
2.08843 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, AURKB, AXL, CBR1, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
2.08499 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 |
2.07873 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, PIK3CB |
2.0651 |
[BP] GO:0033273 |
response to vitamin
|
CYP1A1, PPARG, PTGS2, TYR |
2.0651 |
[BP] GO:0045923 |
None
|
PPARA, PPARG, PTGS2 |
2.0563 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.0563 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2 |
2.0495 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CYP19A1, ESR1, HCAR2, HSP90AA1, HSP90AB1, MMP2, PIK3CA, PIK3CB, PPARG, SRC |
2.03321 |
[BP] GO:0019217 |
None
|
FABP3, PPARA, PPARG, PTGS2 |
2.03282 |
[BP] GO:0006937 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, PTGS2 |
2.0295 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC |
2.02939 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
2.02939 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.02618 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.02513 |
[BP] GO:0051099 |
positive regulation of binding
|
APP, HSP90AB1, MET, MMP9, PPARG |
2.01421 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, MET, MMP9, PIK3CA, PIK3CB, PPARG, SRC, XDH |
2.01078 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, HCAR2, HSP90AB1, MET, PIK3CA, PPARA |
2.0036 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APP, AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH |
2.00079 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, HSP90AA1, HSP90AB1, MET, PTGS2, SRC |
3.14862 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, HSP90AB1 |
2.63816 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FLT3, HCAR2, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, SRC, TYR |
2.61241 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FLT3, HCAR2, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC, TYR |
2.38425 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, ESR1, FLT3, HCAR2, HSP90AA1, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, SRC |
2.32042 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, HSP90AA1, HSP90AB1, PTGS1, SRC |
2.29374 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, HSP90AA1, HSP90AB1, PTGS1, SRC |
2.29374 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
2.29373 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5 |
2.02513 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.8524 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PPARG, TYR, XDH |
15.7789 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, SRC, TYR, XDH |
11.7043 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.6013 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FLT3, HSD17B1, HSD17B2, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, SRC, TYR, XDH |
10.6922 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.4692 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, SRC |
8.2322 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PPARG |
6.98747 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.96005 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.91813 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.91058 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.80719 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.72529 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.6221 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR, XDH |
6.38068 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TYR |
6.38068 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.53411 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR, XDH |
5.33962 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
5.26891 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
5.23764 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.06453 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.23721 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.22882 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.69867 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.64182 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.62614 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PPARG |
3.51638 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.44915 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.32422 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NQO2, PPARG, PTGS2, TYR, XDH |
3.29023 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
3.29023 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.27026 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.1959 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.16202 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.11031 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, HSD17B1, IGF1R, NQO2 |
3.07951 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.00505 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PPARG |
2.95961 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.8949 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.8949 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.8949 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PPARG |
2.82881 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARG, SRC, XDH |
2.80958 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, PPARG |
2.74148 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, PPARG |
2.74148 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.66359 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PPARG |
2.52571 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.52571 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARA, SRC |
2.50635 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, PPARG |
2.47833 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.42552 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD17B1, HSD17B2, XDH |
2.29373 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.29373 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, HCAR2, IGF1R, KDR, MET, PPARG |
2.25229 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, HCAR2, IGF1R, KDR, MET, PPARG |
2.25229 |
[MF] GO:0043168 |
anion binding
|
APP, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARG, SRC, XDH |
2.25042 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.19464 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.19464 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.11966 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PPARA, SRC |
2.07068 |